BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Pharm Country

  Tyber Medical Anatomical Plating System Cleared For Canada

  Tyber Medical LLC, a leading orthopedic device manufacturer providing private label orthopedic implants for the trauma, extremity, and spine markets, received clearance for the anatomical plating system in Canada.

  February 6, 2024

   · 

  2 min read
• SMC Laboratories Reveals Innovative STAM™-HCC/IO+ Mouse for Identifying and Developing Novel Therapeutic Drugs for Liver Cancer, Blazing a Trail in the Immuno-Oncology Field

  SMC Laboratories, Inc. (“SMC Laboratories”) recently launched their innovative STAM™-HCC/IO+ mouse – a first in the field of tumor immuno-oncology – to develop new liver cancer therapeutic drugs.

  February 6, 2024

   · 

  4 min read
• Pharm Country

  Regeneron Announces Investor Conference Presentations - February 06, 2024

  Regeneron Pharmaceuticals, Inc. will webcast management participation as follows.

  February 6, 2024

   · 

  1 min read
• BioCapital

  NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

  NexImmune, Inc. announced the closing of its previously announced registered direct offering of 304,731 shares of its common stock at a purchase price of $12.05 per share in a registered direct offering priced at-the-market under Nasdaq rules.

  February 6, 2024

   · 

  5 min read
• Pharm Country

  Feinstein Institutes research shows that psychiatric disorders are linked to dementia not through genetics, but alcohol use as shared cause

  Dementia is a life-changing disease that alters memory, language and other cognitive functions in more than 55 million people worldwide.

  February 6, 2024

   · 

  3 min read
• Pharm Country

  Preterm Births Linked to ‘Hormone Disruptor’ Chemicals May Cost United States Billions

  Daily exposure to chemicals used in the manufacture of plastic food containers and many cosmetics may be tied to nearly 56,600 preterm births in the U.S. in 2018, a new study shows.

  February 6, 2024

   · 

  5 min read
• Business

  Senta Brandt and Gerrick Rodrigues appointed to Global Leadership Positions at Rentschler Biopharma

  Rentschler Biopharma SE, a leading contract development and manufacturing organization for biopharmaceuticals, including advanced therapy medicinal products, announced that Senta Brandt has been promoted to the global position of Head of Transformation, effective January 1, 2024.

  February 6, 2024

   · 

  4 min read
• Biotech Bay

  Reviva to Host KOL Event to Discuss Topline Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia

  Reviva Pharmaceuticals Holdings, Inc. today announced that it will host a key opinion leader (KOL) event on Thursday, February 15, 2024 at 12:00 PM ET.

  February 6, 2024

   · 

  7 min read
• Genetown

  Astria Therapeutics to Present at Upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference

  Astria Therapeutics, Inc. today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will participate in a fireside chat at the upcoming virtual Oppenheimer 34th Annual Healthcare Life Sciences Conference on Tuesday, February 13th at 9:20am ET.

  February 6, 2024

   · 

  1 min read
• Business

  Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer

  Femasys Inc. today announced the appointment of Richard Spector to chief commercial officer (CCO), effective February 2024.

  February 6, 2024

   · 

  7 min read